References
[1]. Rajeshwari, P., D. Rajeswari, S.K. Jabbirulla, and I. Vishnu vardhan, 2013. Evaluation of in vitro antiurolithiasis activity of Convolvulus arvensis. Int J Pharma Pharmaceu Sci., 5(3): 599-601.
[2]. Khare, P., V.K. Mishra, K. Arun, N. Bais, and R. Singh, 2014. Study on in vitro anti-lithiatic activity of Phyllanthus niruri Linn. Leaves by homogenous precipitation and turbiditory method. Inter J Pharma Pharmaceu Sci., 6(4): 124-127.
[3]. Semins, M.J., and B.R. Matlaga, 2010. Medical evaluation and management of urolithiasis. Ther Adv Urol., 2(1): 3-9.
[4]. Awari, M.D., V. Mute, S.P. Babhale, and P.S. Chaudhar, 2009. Antilithiatic effect of Achyranthes aspera Linn. leaves extract on ethylene glycol induced nephrolithiasis. J Pharma Res., 2: 994-997.
[5]. Shashi, A., S.K. Jain, A. Verma, M. Kumar, and M. Sabharwal, 2013. Pathophysiology of kidney, gallbladder and urinary stones treatment with herbal and allopathic medicine: a review. Asian paci J Trop Dis., 3: 496-504.
[6]. Atodariya, U., R. Barad, S. Upadhyay, and U. Upadhyay, 2013. Anti-urolithiatic activity of Dolichos biflorus seeds. J Pharmacog Phytochem., 2(2): 209-213.
[7]. Moochhala, S.H., J.A. Sayer, G. Carr, and N.L. Simmons, 2008. Renal calcium stones: Insights from the control of bone mineralization. Exp Physiol., 93(1):43-9.
[8]. Kramer, H.J., H.K. Choi, K. Atkinson, M. Stampfer, and G.C. Curhan, 2003. The association between gout and nephrolithiasis in men: the health professionals follow up study. Kidney Int., 64: 1022-6.
[9]. Louis, S., and M.D. Liou, 2009. Kidney stones; diseases and conditions; Pub Med Health.
[10]. Spernat, D., and J. Kourambas, 2011. Urolithiasis-medical therapies. BJU Int., 108 (2): 9-13.
[11]. Prasad, K.V., D. Sujatha, and K. Bharathi, 2007. Herbal drugs in urolithiasis- A review. Phcog Rev., 1: 175-179.
[12]. Bashir, S., and A.H. Gilani, 2009. Antiurolithiatic effect of Bergenia ligulata rhizome: an explanation of the underlying mechanisms. J Ethanopharmacol., 122: 106-116.
[13]. Oliver-Bever, B., 1983. Medicinal plants in tropical West Africa. III. Anti-infection therapy with higher plants. J Ethnopharmacol., 9:1-83.
[14]. Gill, L.S., 1992. Ethno-medical uses of plant in Nigeria. Benin, Nigeria: Uniben Press.
[15]. Okafor, J.C., and R. Ham, 1999. Identification, utilization and conservation of medicinal plants in South Eastern Nigeria. Issues in African biodiversity support programme.
[16]. Chopra, R.N., S.I. Nayar, and I.I. Chopra, 2002. Glossary of Indian Medicinal Plants. New Delhi: NISCIR (CSIR).
[17]. Ghasi, S., C. Egwuib, P.U. Achukwu, and J.C. Onyeanusim, 2011. Assessment of the medical benefit in the folkloric use of Bryophyllum pinnatum leaf among the Igbos of Nigeria for the treatment of hypertension. Afr J Pharm Pharmacol., 5:83-92.
[18]. Okwu, D.E. and Josiah, C. 2006. Evaluation of the chemical composition of two Nigerian medicinal plants. Afr J Biotech, 5:357-61.
[19]. Cao, H., J. Xia, D. Xu, B. Lu, and G. Chen, 2005. The separation and identification of the flavonoids from the leaves of Bryophyllum pinnatum. Zhong Yao Cai., 28:988-90.
[20]. Afzal, M., G. Gupta, I. Kazmi, M. Rahman, O. Afzal, and J. Alam, 2012. Antiinflammatory and analgesic potential of a novel steroidal derivative from Bryophyllum pinnatum. Fitoterapia., 83:853-8.
[21]. Yamagishi T, M. Haruna, X.Z. Yan, J.J. Chang and K.H. Lee, 1989. Antitumor agents, Bryophyllin B, a novel potent cytotoxic bufadienoiide from Bryophyllum pinnatum. J Nat Prod., 52:1071-9.
[22]. Marriage, P.B. and B.G. Wilson, 1971. Analysis of the organic acids of Bryophylum pinnatum. Can J Biochem., 11:1500-2.
[23]. Shukla, A.B., D.R. Mandavia, M.J. Barvaliya, S.N. Baxi, and C.R. Tripathi, 2014. Evaluation of anti-urolithiatic effect of aqueous extract of Bryophyllum pinnatum (Lam.) leaves using ethylene glycol-induced renal calculi. Avicenna J Phytomed., 4: 151–9.
[24]. Yadav, M., V.D. Gulkari, and M.M. Wanjari, 2016. Bryophyllum pinnatum leaf extracts prevent formation of renal calculi in Lithiatic rats. Anc Sci Life., 36(2): 90–97.
[25]. Gahlaut, A., S.D. Pawar, T.K. Mandal, and R. Dabur, 2012. Evaluation of clinical efficacy of Bryophyllum pinnatum for treatment of lithiasis. International journal of pharmacy and pharmaceutical sciences., 2012; 4:505-507.
[26]. Nelson, P.N., G.M. Reynolds, E.E. Waldron, E. Ward, K. Giannopoulos, and P.G. Murray, 2000. Demystified: Monoclonal antibodies. Molecular pathology., 53(3): 111–7.
[27]. Fadeyi, M.O., A.O. Adeoye, and I.D. Olowokudejo, 1987. Epidermal and phytochemical Studies in the genus Bohervia (Nyctaginaceae) in Nigeria. Int. J. Crude drug research., 27: 178-184
[28]. Harbone, J.B., 1998. Phytochemical methods: A guide to modern techniques of plant analysis. 3rd Edition. Chapman and Hill, London. p.279.
[29]. Sasikala, V., S.R. Radha, and B. Vijayakumari, 2013. In vitro evaluation of Rotula aquatica Lour. For antiurolithiatic activity. J Pharm Res., 6(3):378-82.
[30]. Rao, T.V., and S. Bano, 2004. In-vitro chemodissolution of urinary stones by some chelating natural acids. Asian J Chem., 16(1):59.
[31]. Salhan, M., B. Kumar, P. Tiwari, P. Sharma, H.K. Sandhar, and M. Gautam, 2011. Comparative Anthelmintic Activity of aqueous and ethanolic leaf extracts of Clitoria ternatea. International Journal of Drug Development and Research., 3 (1): 68-69.
[32]. Eweka, A.O., and Adaze Enogieru. 2011. Effects of oral administration of Phyllanthus amarus leaf extract on the kidneys of Adult wistar rats-A Histological study. African Journal of Traditional Complementary and Alternative Med., 8(3): 307-311.
[33]. Francis, G., 2002. The biological action of saponins in animal systems: a review. British Journal of Nutrition., 88(6): 587-605.
[34]. Rad, A.K., M.A.R. Hajzadeh, Z. Rajaei, M.H. Sadeghian, and Z. Keshavarzi, 2011. Preventive effect of Cynodon dactylon against ethylene glycol-induced nephrolithiasis in male rats. Avicenna Journal of Phytomedicine.,1: 14–23.
[35]. Qiao, D., L.S. Gan, J.X. Mo, and C.X. Zhou, 2012. Chemical constituents of Acorus calamus. Zhongguo Zhong Yao Za Zhi., 37: 3430-3433.
[36]. Varsha, J., D. Swati, and M. Shivprasad, 2013. The evaluation of antioxidant potential of Clitoria ternatea L. International Journal of Pharmaceutical Science., 5(2): 595-599.
[37]. Menon, M., and M.I. Resnick, 2002. Urinary lithiasis: Etiology, diagnosis and medical management. In: Walsh, P.C., Retik, A.B., Vaughan, E.D. Jr, Wein, A.J., editors. Campbell’s Urology. 7th ed. Philadelphia, PA: WB Saunders; 2661-733.
[38]. Basavaraj, D.R., C.S. Biyani, A.J. Browning, and J.J. Cartledge, 2007. The role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones. EAU-EBU update series., 5(3):126-36.
[39]. Aggarwal, K.P., S. Narula, M. Kakkar, and C. Tandon, 2013. Nephrolithiasis: molecular mech¬anism of renal stone formation and the critical role played by modulators. Biomed Res Int., 29: 29-53.
[40]. Sujatha, D., K. Singh, M. Vohra, K.V. Kumar, and S. Sunitha, 2015. Antilithiatic activity of phlo¬rotannin rich extract of Sarghassum wightii on calcium oxalate urolithiasis– in vitro and in vivo evaluation. Int Braz J Urol., 41(3):511-20.
[41]. Niharika, M., N. Suchitha, S. Akhila, J. Himabindhu, and K. Ramanjaneyulu, 2018. Evaluation of in vitro antiurolithiatic activity of Gossypium Herbaceum. J. Pharm. Sci. and Res., 10(5): 1236-1237
[42]. Bawari, S., A.N. Sah, and D. Tewari, 2018. Antiurolithiatic activity of Daucus carota: an in vitro study. Pharmacog J., 10(5):880-884